Blood Collection Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

The Blood Collection Market is Segmented by Product (Needles and Syringes, Tubes, Lancets, Blood Bags, and Other Products), Application (Diagnostics and Treatment), End User (Hospitals and Diagnostic Centers, Blood Banks, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the market size and forecasts in value (USD million) for the above segments.

Blood Collection Industry Overview

Blood Collection Market Summary
Study Period: 2018 - 2028
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 6.2 %

Major Players

Blood Collection Market Major Players

*Disclaimer: Major Players sorted in no particular order


Need a report that reflects how COVID-19 has impacted this market and its growth?

Blood Collection Market Analysis

The Blood Collection Market is expected to grow at a CAGR of 6.2% during the forecast period, 2022-2027.

The outbreak of COVID-19 worldwide is expected to positively impact the market because blood testing involves the testing of various blood samples, which helps diagnose infectious diseases such as COVID-19. Testing remains a crucial step in controlling the COVID-19 pandemic. As the number of COVID-19 cases is increasing worldwide, governments across the globe are exploring the possibilities of allowing private laboratories to ramp up blood testing. Moreover, the blood reserves have been depleting due to the virus outbreak. Many individuals with weak immune systems who have been infected by COVID-19 and are hospitalized need a blood/plasma transfusion. Many governments are also taking initiatives to help increase blood donation. For instance, in June 2020, the Maharashtra state government in India used social media initiatives to increase the number of blood donations. The move was taken following the shortage of blood in the region. Such programs have positively impacted the global blood collection market growth in many regions during the pandemic.

Specific factors driving the market growth include the rising demand for early diagnosis of chronic conditions, increasing incidence of trauma and accidents, and a surge in the number of surgical procedures carried out worldwide.

Blood collection has also witnessed a great demand due to an increased number of patients suffering from various ailments related to blood, kidney, metabolic diseases, and neurological disorders. Cancers such as leukemia, lymphoma, myeloma, and myelodysplastic syndromes (MDS) can affect the bone marrow, blood cells, lymph nodes, and other parts of the lymphatic system. It has been observed that apheresis technology has been used to reduce the number of white cells until other medications can control them. According to the Leukemia and Lymphoma Society (LLS) Factsheet 2021, approximately every three minutes, one person in the United States is diagnosed with blood cancer. Moreover, as per the same source, 186,400 people in the United States will be diagnosed with leukemia and lymphoma in 2021. In addition, 825,651 people lived with lymphoma in the United States, 152,671 people resided with Hodgkin lymphoma, and 672,980 people lived with non-Hodgkin lymphoma.

Moreover, the growing number of accidents also boosts the market growth. According to the World Health Organization, 2020, 1.35 million people die yearly from road accidents, and 20-50 million suffer from non-fatal injuries. The increasing number of accidents drives the demand for blood products, boosting the market growth.

The steady increase in the number of patients suffering from these diseases and ailments and the growing number of accidents may boost the blood collection market during the forecast period. However, blood contamination, other complications, and injuries caused during the blood collection are the major restraining factor for the market studied.

Blood Collection Industry Segments

Blood specimen collection is a procedure performed routinely to obtain blood for various laboratory tests. Blood can be collected from venous access devices and occasionally by fingerstick. However, it is most frequently obtained via a peripheral vein puncture, also called venipuncture. The blood collection market is segmented by product (needles and syringes, tubes, lancets, blood bags, and other products), application (diagnostics and treatment), end user (hospitals and diagnostic centers, blood banks, and other end users), and geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major global regions. The report offers the market size and forecasts in value (USD million) for the above segments.

By Product
Needles and Syringes
Tubes (Plasma-separating Tubes, Serum-separating Tubes, etc.)
Blood Bags
Other Products
By Application
By End User
Hospitals and Diagnostic Centers
Blood Banks
Other End Users
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Blood Collection Market Trends

This section covers the major market trends shaping the Blood Collection Market according to our research experts:

Needles and Syringes are Expected to Hold a Significant Market Share

The immediate detection of COVID-19 cases requires the wide availability of diagnostics to control the virus's rapid spread. A public health emergency was determined, justifying the authorization of emergency use of in vitro diagnostics (IVDs) to diagnose COVID-19, which ultimately drives blood testing worldwide. Hence, the needles and syringes segment is expected to see healthy growth over the forecast period. Using hypodermic needles and syringes is the most common means of blood sampling. Therefore, blood collection needles and syringes are expected to dominate the market owing to their extensive use all across the globe.

Apart from the pandemic, many other infectious diseases are prevalent, increasing the demand for blood specimen collection for diagnosis, thereby boosting the demand for needles and syringes for blood collection. For instance, in the study titled "The Order of Draw during Blood Collection: A Systematic Literature Review," published in the MDPI Journal in February 2021, a syringe with a needle is a common open blood collection system. Syringes are an essential part of any phlebotomist's blood-collection device toolkit. Thus, the demand for syringes and needles in fore blood collection boosted the segment growth over the forecast period.

Various advancements in the field of medical devices are also fueling market growth. For example, According to the study titled "Variation of the Penetration Effort in an Artificial Tissue by Hypodermic Needles," published in the Hindwi Journal in September 2020, siliconized needles are currently being used in multiple instances to minimize trauma and minimize the risk of vein cross perforation with a short bevel. Because a vast number of injuries occur within seconds after an invasive device is removed from the vein, the majority of the marketed needles provide immediate protection at the puncture site. Hence, this segment is expected to retain its dominance in the global market over the forecast period.

Blood Collection Market : Deaths Due To Chronic Diseases (In Million), By Disease Type, Global, 2020

North America Dominates the Market and is Expected to do the Same in the Forecast Period

North America holds the largest share of the market studied, which is attributed to the increasing demand for blood collection products. An increase in the number of road accidents and the rising prevalence of chronic diseases are the major factors driving the growth of the market studied. With the COVID-19 impact being the highest in the United States, the region foresees good growth in the market during the forecast period.

According to the American National Red Cross, 2021 updated estimates, approximately 36,000 units of red blood cells are needed every day, and nearly 21 million blood components are transfused each year in the United States. Additionally, according to the Globocan 2020 report, Canada had 8,506 cases of Non-Hodgkin lymphoma and 313 deaths caused due to it in 2020. The increase in cases of Non-Hodgkin lymphoma is expected to boost the demand for the blood collection market.

However, various strategies acquired by the key market players in the country anticipated market growth. For instance, in December 2021, Ethos Laboratories, a College of American Pathologists-accredited and certified leader in diagnostic testing services, launched Tru-Immune, a finger prick, self-collection kit for its COVID-19 neutralizing antibody test.

Additionally, in December 2021, Tasso, a maker of simplified blood collection devices. After raising only USD 17 million to begin operations in mid-2020, the company has raised USD 100 million to expand its production and commercial reach for advanced at-home blood collection devices. The growing number of chronic diseases and lifestyle-related disorders requires blood collection for their diagnosis, which boosts the region's market growth.

Blood Collection Market : Growth Rate by Region

Blood Collection Market Competitor Analysis

The blood collection market is highly competitive and consists of several major players. Companies like Becton, Dickinson and Company, Cardinal Health, F.L. Medical SRL, Greiner Bio-One International GmbH, Haemonetics Corporation, Henry Schein Inc., McKesson Corporation, Medline Industries Inc., PreQ Systems, and Qiagen, among others, hold substantial shares in the market.

Blood Collection Market Top Players

  1. Cardinal Health

  2. Becton Dickinson and Company

  3. Medline Industries, Inc.

  4. Greiner Bio One International GmbH

  5. Henry Schein, Inc.

*Disclaimer: Major Players sorted in no particular order

Blood Collection Market Concentration

Blood Collection Market Recent Developments

  • In February 2022, Abacus dx launched the newest addition to Streck’s trusted blood collection tube portfolio, RNA Complete BCT.
  • In February 2022, BD (Becton, Dickinson and Company) released UltraSafe Plus 2.25 mL, a new needle guard solution that improves the delivery of drugs and other biologic solutions.

Blood Collection Market Report - Table of Contents


    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Demand for Early Diagnosis of Chronic Conditions

      2. 4.2.2 Increasing Incidence of Trauma and Accidents

      3. 4.2.3 Surge in the Number of Surgical Procedures Carried Out Worldwide

    3. 4.3 Market Restraints

      1. 4.3.1 Blood Contaminations and Other Complications

      2. 4.3.2 Injury Caused During Blood Collection

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value)

    1. 5.1 By Product

      1. 5.1.1 Needles and Syringes

      2. 5.1.2 Tubes (Plasma-separating Tubes, Serum-separating Tubes, etc.)

      3. 5.1.3 Lancets

      4. 5.1.4 Blood Bags

      5. 5.1.5 Other Products

    2. 5.2 By Application

      1. 5.2.1 Diagnostics

      2. 5.2.2 Treatment

    3. 5.3 By End User

      1. 5.3.1 Hospitals and Diagnostic Centers

      2. 5.3.2 Blood Banks

      3. 5.3.3 Other End Users

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Becton, Dickinson and Company

      2. 6.1.2 Cardinal Health

      3. 6.1.3 Terumo Corporation

      4. 6.1.4 FRESENIUS KABI

      5. 6.1.5 Haemonetics Corporation

      6. 6.1.6 Henry Schein Inc.

      7. 6.1.7 McKesson Corporation

      8. 6.1.8 Medline Industries Inc.

      9. 6.1.9 PreQ Systems

      10. 6.1.10 Qiagen

      11. 6.1.11 Grifols

      12. 6.1.12 Smiths Medical

      13. 6.1.13 Quest Diagnostics

      14. 6.1.14 Nipro Medical Corporation

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You can also purchase parts of this report. Do you want to check out a section wise price list?

Blood Collection Market Research FAQs

The Global Blood Collection Market is studied from 2018 - 2028.

The Global Blood Collection Market is growing at a CAGR of 6.2% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2018 - 2028.

North America holds highest share in 2021.

Cardinal Health, Becton Dickinson and Company, Medline Industries, Inc., Greiner Bio One International GmbH, Henry Schein, Inc. are the major companies operating in Global Blood Collection Market.

Global Blood Collection Industry Reports

In-depth industry statistics and market share insights of the Global Blood Collection sector for 2020, 2021, and 2022. The Global Blood Collection research report provides a comprehensive outlook of the market size and an industry growth forecast for 2023 to 2028. Available to download is a free sample file of the Global Blood Collection report PDF.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!